LH Stock Analysis: Buy, Sell, or Hold?
LH - Labcorp Holdings Inc.
$332.81
2.37 (0.72%)
▲
5d:
+3.17%
30d:
+18.24%
90d:
+29.29%
WAIT
LOW Confidence
Analysis Updated: Aug 20, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When LH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LH shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$379.30
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$235.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LH is currently trading at $332.81, which is considered extended relative to its 30-day fair value range of $286.78 to $323.78. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.8) compared to its historical average (14.4). At these levels, the market is pricing in 5.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LH is in a strong uptrend. The price is approaching resistance at $338.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LH scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LH is in a strong uptrend. The price is approaching resistance at $338.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LH scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$286.78 -
$323.78
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
37.7%
Protect Your Profits
LH is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($337.75)
- NEUTRAL: Trading at premium valuation - market expects 5.3% growth which is achievable
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$286.78 -
$323.78
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.45
(2.2%)
Support & Resistance Levels
Support Level
$313.32
Resistance Level
$338.19
Current Trend
Strong Uptrend
Technical data as of
Aug 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.82
Wall Street Target
$337.75
(+1.5%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
28.2%
Profit Margin
7.0%
Valuation Premium vs History
+5.3% premium
PE vs Historical
16.8 vs 14.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$350.45
(+5%)
2-Year Target
$369.02
(+11%)
3-Year Target
$388.58
(+17%)
3-Yr Target (if PE normalizes)
(PE: 17→14)
PE COMPRESSION
$332.63
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.8%)
$497.87
(+50%)
Base:
(SPY PE: 16.8, Growth: 7.8%)
$417.31
(+25%)
Bear:
(PE: 14.3, Growth: 7.8%)
$354.71
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 26.67 | Current EPS (TTM): $12.08
Bull Case
$580.41
(+74%)
Analyst growth 63.8%, PE expands to 29.3
Base Case
$527.64
(+59%)
Market implied 63.8%, PE stable at 26.7
Bear Case
$219.08
(-34%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 21, 2026 4:57 AM ET
Data refreshes hourly during market hours. Next update: 5:57 AM
Data refreshes hourly during market hours. Next update: 5:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam H Schechter
SELL
8705 shares
2026-03-03
Der Vaart Sandra D Van
SELL
548 shares
2026-02-27
Brian J Caveney
SELL
1500 shares
2026-02-24
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 43 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
Advanced LH Option Strategies
Professional options setups generated by AI based on today's LH price and gamma walls.
